Phenytoin-induced gingival enlargement: A dental awakening for patients with epilepsy

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Mohan, Ravi Prakah Sasankoti ^a   Rastogi, Khushboo ^a   Bhushan, Rajarshi ^a   Verma, Sankalp ^a  

^a Kothiwal Dental College Research Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN;

ADULT; ARTICLE; CASE REPORT; CONSULTATION; DISEASE ASSOCIATION; EPILEPSY; GINGIVA HYPERPLASIA; HUMAN; MALE; MOUTH EXAMINATION; MOUTH HYGIENE; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 84878512115     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-008679     Document Type: Article

References (7)

1. Rees TD, Levine RA. Systemic drugs as a risk factor for periodontal disease initiation and progression. Compend Contin Educ Dent 1995;16:20-42.
2. Newman C. Glickman's clinical periodontology. 8th edn. Philadelphia, USA: WB Saunders Co. 1997:233.
3. Kimball OP. The treatment of epilepsy with sodium diphenyl hydantoinate. J Am Med Assoc 1939;112:1244-5.
4. Angelopoulos AP. Diphenhydantoin gingival hyperplasia. A clinicopathological review. Incidence, clinical features and histopathology. J Can Dent Assoc 1975;41:103-6.
5. Panuska HJ, Gorlin RJ, Bearman JE. The effect of anti convulsants drugs upon the gingiva: a series of 1048 patients. J Periodontol 1961;32:15-20.
6. Lowenstein DR. Seizures and epilepsy. In: Fanci AS, Braunwald E, Isselbacher KJ, et al. Harrison's principles of internal medicine. New York: McGraw-Hill, 1991:23l1-2r.
7. Brunet L, Miranda J, Roset P, et al . Prevalence and the risk of gingival enlargement in patients treated with anticonvulsant drugs. Fur J Clin Invest 2001;31:781-8. (Pubitemid 34203472)